Literature DB >> 31383671

Interesting pancreatic tumour in the background of Tuberous Sclerosis.

Jmv Amarjothi1, Jeyasudhahar Jesudason1, Villalan Ramasamy1, Ol Naganath Babu2.   

Abstract

Tuberous Sclerosis Complex (TSC) is easily discernible by a myriad of manifestations, most notably dermatological. It is associated with well known and recognised intra-abdominal tumours like angiomyolipoma of the kidney. However, rarer tumours like pancreatic neuroendocrine tumours can occur in the setting of TSC. A high index of suspicion is necessary to identify and treat these lesions early in their natural course. Early identification augurs well with complete surgical excision and excellent survival. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  pancreatic neuroendocrine tumor; tuberous sclerosis

Mesh:

Year:  2019        PMID: 31383671      PMCID: PMC6685411          DOI: 10.1136/bcr-2018-227292

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.

Authors:  Hope Northrup; Darcy A Krueger
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

2.  Pancreatic tumors in children and young adults with tuberous sclerosis complex.

Authors:  Gonca Koc; Sam Sugimoto; Rachel Kuperman; Bamidele F Kammen; S Pinar Karakas
Journal:  Pediatr Radiol       Date:  2016-09-17

3.  Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex.

Authors:  A M Larson; S S Hedgire; V Deshpande; A O Stemmer-Rachamimov; M G Harisinghani; C R Ferrone; U Shah; E A Thiele
Journal:  Clin Genet       Date:  2011-11-29       Impact factor: 4.438

Review 4.  Role of surgery in pancreatic neuroendocrine tumor.

Authors:  Kai Pun Wong; Julian Shun Tsang; Brian Hung-Hin Lang
Journal:  Gland Surg       Date:  2018-02

5.  Cystic pancreatic neuroendocrine tumors: To date a diagnostic challenge.

Authors:  Pietro Caglià; Maria Teresa Cannizzaro; Angelo Tracia; Luca Amodeo; Luciano Tracia; Antonino Buffone; Corrado Amodeo; Matteo Angelo Cannizzaro
Journal:  Int J Surg       Date:  2015-06-26       Impact factor: 6.071

Review 6.  Surveillance strategy for small asymptomatic non-functional pancreatic neuroendocrine tumors - a systematic review and meta-analysis.

Authors:  Ville Sallinen; Tessa Y S Le Large; Shamil Galeev; Zahar Kovalenko; Elke Tieftrunk; Raphael Araujo; Güralp O Ceyhan; Sebastien Gaujoux
Journal:  HPB (Oxford)       Date:  2017-02-21       Impact factor: 3.647

7.  Can pancreatic neuroendocrine tumour biopsy accurately determine pathological characteristics?

Authors:  Vinciane Rebours; Jacqueline Cordova; Anne Couvelard; Monique Fabre; Laurent Palazzo; Marie Pierre Vullierme; Olivia Hentic; Alain Sauvanet; Alain Aubert; Pierre Bedossa; Philippe Ruszniewski
Journal:  Dig Liver Dis       Date:  2015-06-20       Impact factor: 4.088

8.  An estimate of the heritable fraction of childhood cancer.

Authors:  S A Narod; C Stiller; G M Lenoir
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

Review 9.  Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment.

Authors:  Cynthia Ro; Wanxing Chai; Victoria E Yu; Run Yu
Journal:  Chin J Cancer       Date:  2012-12-14

10.  Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis.

Authors:  Yusuke Ohara; Tatsuya Oda; Shinji Hashimoto; Yoshimasa Akashi; Ryoichi Miyamoto; Tsuyoshi Enomoto; Kaishi Satomi; Yukio Morishita; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

View more
  1 in total

Review 1.  Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.

Authors:  R M Ruggeri; E Benevento; F De Cicco; B Fazzalari; E Guadagno; I Hasballa; M G Tarsitano; A M Isidori; A Colao; A Faggiano
Journal:  J Endocrinol Invest       Date:  2022-08-30       Impact factor: 5.467

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.